However, the honest caveat is decisive
Similarly, there are reports of patients with psoriasis and metabolic syndrome being treated with GLP-1 receptor agonists in clinical practice, with some suggesting potential improvements in inflammatory markers, though causality cannot be established from these observations
Michigan State University researcher Gina Leinninger explains how the drug works and why its so hard to lose weight
Three Things Most People Get Wrong About Weight Loss Drugs They think the drug does the work
Participants in the semaglutide group achieved a weight loss of at least 5%, 10%, or 15%, and improvements in secondary endpoints, such as waist circumference, blood pressure, and lipid levels, compared to the placebo group
Rare cases of intestinal obstruction have been reported with some agents